3+ hour, 4+ min ago  (226+ words) Are large language models the Swiss Army knife or the Scalpel for clinical research. Gen AI is rapidly entering oncology. In just a few years, large language models have gone from curiosity to tools that can summarize literature, assist clinicians,…...

2+ day, 4+ hour ago  (141+ words) Arturo LoAIza-Bonilla: Thrilled to take the stage at Ai4 - Artificial Intelligence Conferences 2026Oncodaily Arturo LoAIza-Bonilla: Thrilled to take the stage at Ai4 " Artificial Intelligence Conferences 2026 Arturo LoAIza-Bonilla, Systemwide Chief of Hematology and Oncology at St. Luke's University Health Network, and Co-Founder and Chief…...

1+ mon, 1+ week ago  (243+ words) Tanja Obradovic, Oncology Medical Strategy Adviser, Clinical Drug Development Expert, shared a post by HopeAI on LinkedIn, adding: "Great opportunity for drug development community to stay on top of trends and news about AI inroads by following HopeAI podcasts as…...

1+ mon, 4+ week ago  (252+ words) Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared a post by TensorBlack on LinkedIn, adding: "New…...

1+ mon, 4+ week ago  (110+ words) Patrick Soon-Shiong: The World's First AI-Driven Robot to Manufacture NK Cells at Scale'Oncodaily Patrick Soon-Shiong: The World's First AI-Driven Robot to Manufacture NK Cells at Scale Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive…...

2+ mon, 2+ day ago  (514+ words) The initiative is led by three principal investigators: CRI STARs Andrea Schietinger, Ph.D., and Ansuman Satpathy, M.D., Ph.D., and CRI Scientific Advisory Council Associate Director, E. John Wherry, Ph.D. Alicia Zhou, Ph.D., CEO of CRI, said: Most critical immunotherapy research data today…...

2+ mon, 1+ week ago  (210+ words) Julie Magarian Blander, Scientist and Professor at Weill Cornell Medicine, shared a post by Jonathan Lim, Lead of RISE Consortium, on LinkedIn, adding: "Jonathan Lim, Caetano Reis e Sousa and colleagues show cDC1s and DNGR1 favor "tethered" neoantigens from F-actin proteins (FABP),…...